Solarvest BioEnergy Grants Options
25 June 2011 - 7:55AM
Marketwired
SOLARVEST BIOENERGY INC. (TSX VENTURE: SVS) ("Solarvest" or the
"Company") is pleased to announce that it has granted to Dr. Angela
Riveroll 70,000 options exercisable at a price of $0.25 per common
share for a period of five years from the grant date. As Senior
Research Scientist at Solarvest (PEI) Inc., Dr. Riveroll will take
a leading role in the company's genetic program to produce hydrogen
from its proprietary strains of algae.
About Solarvest: Solarvest is committed to the development of
sustainable and renewable energy sources to meet growing energy
demands and environmental challenges. Solarvest's intellectual
property is a biologically-based hydrogen producing technology,
which provides a method for controlling key genes in algae
resulting in the continuous production of hydrogen gas. Solarvest's
bio-energy production system utilizes light and carbon dioxide to
produce hydrogen leaving a clean positive environmental
footprint.
The statements made in this news release may contain
forward-looking statements that may involve a number of risks and
uncertainties. Actual events or results could differ materially
from the Company's expectations and projections.
The TSX Venture Exchange has neither approved nor disapproved
the contents of this news release. Neither TSX Venture Exchange nor
its Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Contacts: Solarvest BioEnergy Inc. Gerri Greenham Chief
Executive Officer 416 420 0947 ggreenham@solarvest.ca
Solarvest BioEnergy (TSXV:SVS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Solarvest BioEnergy (TSXV:SVS)
Historical Stock Chart
From Jul 2023 to Jul 2024